NeuroPace logo

NeuroPace

NPCE | NASDAQ
Chart Builder DCF Calculator
$7.97
+$0.41 (+5.42%)
At close: Nov 16, 2026, 4:00 PM ET
$7.82
-$0.15 (-1.88%)
After-hours: Nov 16, 2026, 7:39 PM ET
+5.42%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 16, 2026
43.2
-1.0 pts
Fundamentals Average
Market Sentiment Neutral
Moat Narrow
Sector Rank #440/1021 (Top 43%)

Key Statistics

Market Data

Market Cap $274.58M
1D Range
7.05 8.18
52W Range
7.05 19.29

Valuation (TTM)

PE -14.23
PB 23.89
EV/EBITDA -26.70

Valuation (NTM)

Forward PE N/A
Forward PEG 0.55
Price Target $20.50
Loading financial charts...

Profile

NeuroPace, Inc. operates as a medical device company in the United States. The company develops RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at...

Sector Healthcare
Employees 220
IPO Date Apr 22, 2021
Fiscal Year January - December

Latest News

No news articles available yet.

Earnings

Latest Earnings
Nov 12, 2026
EPS
-$0.1
Beat +8.05%
REV
$23.1M
Miss -14.82%
Next Earnings
Mar 2, 2027
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

Analyst Summary

# of Analysts
3
Consensus
Buy
Price Target
$14.00
Upside
+75.66%
Buy (3)
Hold (0)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.